Show simple item record

dc.creatorClaassen, Dirken
dc.date.accessioned2016-01-08T23:21:41Zen
dc.date.available2016-01-08T23:21:41Zen
dc.date.created2007-04en
dc.date.issued2007-04en
dc.identifierdoi:10.1136/jme.2006.016188en
dc.identifier.bibliographicCitationJournal of Medical Ethics 2007 April; 33(4): 189-193en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Financial+incentives+for+antipsychotic+depot+medication:+ethical+issues&title=Journal+of+Medical+Ethics+&volume=33&issue=4&date=2007-04&au=Claassen,+Dirken
dc.identifier.urihttp://dx.doi.org/10.1136/jme.2006.016188en
dc.identifier.urihttp://hdl.handle.net/10822/965351en
dc.description.abstractBACKGROUND: Giving money as a direct incentive for patients in exchange for depot medication has proved beneficial in some clinical cases in assertive outreach (AO). However, ethical concerns around this practice have been raised, and will be analysed in more detail here. Method: Ethical concern voiced in a survey of all AO teams in England were analysed regarding their content. These were grouped into categories. RESULTS: 53 of 70 team managers mentioned concerns, many of them serious and expressing a negative attitude towards giving money for depot adherence. Four broad categories of ethical concern following Christensen's concept were distinguished: valid consent and refusal (n = 5), psychiatric paternalism (n = 31), resource allocation (n = 4), organisational relationships (n = 2), with a residual category others and unspecified (n = 11). DISCUSSION: The main concerns identified are discussed on the background of existing ethical theories in healthcare and the specific problems of community mental health and AO. Points for practice are derived from this discussion. A way forward is outlined that includes informed consent and an operational policy in the use of incentives, further randomised controlled trials and qualitative studies, and continuing discussions with all stakeholders, especially service users.en
dc.formatArticleen
dc.languageenen
dc.sourceeweb:305907en
dc.subjectConsenten
dc.subjectHealthen
dc.subjectIncentivesen
dc.subjectInformed Consenten
dc.subjectMental Healthen
dc.subjectManagersen
dc.subjectPaternalismen
dc.subjectPatientsen
dc.subjectResource Allocationen
dc.subjectStakeholdersen
dc.subjectSurveyen
dc.subject.classificationPsychopharmacologyen
dc.subject.classificationEconomics of Health Careen
dc.titleFinancial Incentives for Antipsychotic Depot Medication: Ethical Issuesen
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2019 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885